News Releases
Update regarding the Option Agreement for the Dory Property and the Change of Business
Vancouver, British Columbia – TheNewswire – February 24, 2023 – Lexston Life Sciences Corp. (the “Company”) (CSE:LEXT) (OTC:LEXTF) provides an…
 |
|||||||||
Vancouver, British Columbia – TheNewswire – February 24, 2023 – Lexston Life Sciences Corp. (the “Company”) (CSE:LEXT) (OTC:LEXTF) provides an update on the Dory Property Option Agreement dated January 18, 2023 and the change of business announced by the Company’s news release dated January 18, 2023.
The Company is in the process of completing National Instrument 43-101 Technical Report on the Dory Property located in British Columbia. The Company expects to have the completed technical report within approximately four to eight weeks.
Trading of the Company’s common shares on the Canadian Securities Exchange (the “CSE”) will be halted and will remain halted until the documentation required by the Exchange, including the technical report, are filed and accepted.
On Behalf of the Board of Directors
LEXSTON LIFE SCIENCES CORP.
Jagdip Bal Chief Executive Officer
Telephone: (604) 928-8913
The Canadian Securities Exchange has not reviewed and does not accept responsibility for the adequacy or accuracy of the content of this news release.
Copyright (c) 2023 TheNewswire – All rights reserved.
cse
canadian securities exchange
otc
cse-lext
lexston-life-sciences-corp
press-release
nDatalyze Corp. (“NDAT” or the “Corporation”) (CSE:NDAT) (OTC:NDATF) Announces an Expansion of its YMI Validation Project
Calgary, Alberta – TheNewswire – October 17, 2023 – nDatalyze Corp. (“NDAT” or the “Corporation”) (CSE:NDAT) (OTC:NDATF) announces an expansion…
Telo Genomics Announces Clinical Launch of Non-Invasive Cancer Diagnostic, TeloViewSMM – An Important Commercial Milestone Achieved
TeloView Analyses Telomeres to Accurately Predict and Characterize Multiple MyelomaToronto, Ontario–(Newsfile Corp. – October 17, 2023) – Telo Genomics…
NervGen Pharma Appoints John Ruffolo to Board of Directors
Extensive experience in private equity, venture capital and advising high growth, innovative companiesBrings personal experience and knowledge of spinal…
